Last update 08 Jun 2026
Kananji Pharmaceutical Technology (Shanghai) Co., Ltd.

Kananji Pharmaceutical Technology (Shanghai) Co., Ltd.

Subsidiary Company|2006|Shanghai Shi, China|
www.anewpharma.com

Overview

Tags

Neoplasms
Digestive System Disorders
Hemic and Lymphatic Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Neoplasms1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
PDGFRs x VEGFR1

Related

1
Drugs associated with Kananji Pharmaceutical Technology (Shanghai) Co., Ltd.
Vorolanib
Target
PDGFRs x VEGFR
Mechanism
PDGFR antagonists [+1]
Active Org.
EyePoint, Inc.EyePoint, Inc. [+2]
Originator Org.
Tyrogenex, Inc.Tyrogenex, Inc.
Active Indication
Renal Cell Carcinoma [+12]
Inactive Indication
Advanced Renal Cell Carcinoma [+13]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
China
First Approval Date07 Jun 2023
2
Clinical Trials associated with Kananji Pharmaceutical Technology (Shanghai) Co., Ltd.
CTR20192693
/ TerminatedPhase 1
CM082治疗继发于病理性近视的脉络膜新生血管（mCNV）的I期临床研究
[Translation] Phase I clinical study of CM082 for the treatment of choroidal neovascularization (mCNV) secondary to pathological myopia
CTR20160487
/ Not yet recruitingPhase 1
CM082 片治疗难治性和复发性Flt-3 阳性急性髓系白血病的安全性和耐受性I 期临床试验
[Translation] Phase I clinical trial on the safety and tolerability of CM082 tablets in the treatment of refractory and relapsed Flt-3-positive acute myeloid leukemia
100 Clinical Results associated with Kananji Pharmaceutical Technology (Shanghai) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Kananji Pharmaceutical Technology (Shanghai) Co., Ltd.
Login to view more data
100 Deals associated with Kananji Pharmaceutical Technology (Shanghai) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Kananji Pharmaceutical Technology (Shanghai) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Vorolanib
 ( PDGFRs x VEGFR )		Advanced Malignant Solid Neoplasm
More
Phase 1
Scicinib
 ( RNRs )		Hematologic Neoplasms
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free